Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C24H30N6O4 |
| Molecular Weight | 466.5328 |
| Optical Activity | ( - ) |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)C(=O)C1=C(O)C(NC2=C(N[C@@H](C3=NN(C)C=C3C)C4(C)CCCC4)C(=O)C2=O)=CC=N1
InChI
InChIKey=WZBSYWCLIMRAHO-QFIPXVFZSA-N
InChI=1S/C24H30N6O4/c1-13-12-30(5)28-15(13)22(24(2)9-6-7-10-24)27-17-16(20(32)21(17)33)26-14-8-11-25-18(19(14)31)23(34)29(3)4/h8,11-12,22,27,31H,6-7,9-10H2,1-5H3,(H,25,26)/t22-/m0/s1
| Molecular Formula | C24H30N6O4 |
| Molecular Weight | 466.5328 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 15:48:24 GMT 2025
by
admin
on
Wed Apr 02 15:48:24 GMT 2025
|
| Record UNII |
X88GCV5DSA
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000018133
Created by
admin on Wed Apr 02 15:48:24 GMT 2025 , Edited by admin on Wed Apr 02 15:48:24 GMT 2025
|
PRIMARY | |||
|
146444831
Created by
admin on Wed Apr 02 15:48:24 GMT 2025 , Edited by admin on Wed Apr 02 15:48:24 GMT 2025
|
PRIMARY | |||
|
2413693-96-4
Created by
admin on Wed Apr 02 15:48:24 GMT 2025 , Edited by admin on Wed Apr 02 15:48:24 GMT 2025
|
PRIMARY | |||
|
X88GCV5DSA
Created by
admin on Wed Apr 02 15:48:24 GMT 2025 , Edited by admin on Wed Apr 02 15:48:24 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET->WEAK INHIBITOR |
Kd
|
||
|
TARGET -> INHIBITOR |
Kd
|
||
|
TARGET -> INHIBITOR |
Blocked in vitro CCL20-dependent human T cell chemotaxis. slow dissociation rate and consequent prolonged residence time of PF-07054894 on CCR6 is consistent with its insurmountable pattern of chemotaxis inhibition.
IC50
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
